In the United States, more than 200,000 men are diagnosed with prostate cancer each year, making it the most common cancer and second leading cause of cancer death in men in this country.
Prostate cancer surgery is actually one of the most common uses for robotic surgical technology.
Since prostate cancer surgery not only involves the removal of the prostate gland, but also the sewing and rerouting of the urinary tract in a difficult area to reach, the pelvis, robotic surgery can help improve the surgeon’s precision, dexterity and visualization while operating.
With prostate cancer surgery, main outcome goals include good cancer control, as well as preserving urinary control and erectile function.
Robotic surgery, as an option in minimally invasive techniques, not only reduces bleeding risk, pain level and recovery time, it can also improve outcomes specific to prostate cancer surgery.
A prostate cancer diagnosis can certainly evoke fear and anxiety in an individual, and it is important for patients to become their own advocate when discussing treatment options with their doctor.
If surgery is a recommended part of the treatment plan, patients should inquire about their surgeon’s experience and outcomes with robotic surgery, as the technology is only an extension of the surgeon’s expertise.
Fortunately, Cone Health has an exceptional network of urologists that are dedicated to receiving continued education and training to utilize evolving robotic technology and improve patient experience.
Dr. Les Borden is a urologist at Alliance Urology and a member of the Cone Health Medical Staff.
Dr. Borden is a 2000 graduate of Ohio State University College of Medicine. He completed his residency in urology at Wake Forest University Baptist Medical Center and a fellowship in laparoscopy and urologic oncology at Virginia Mason Medical Center.